round button
Leave a message

Global API Contract Manufacturing Market - Industry Trends and Forecast to 2028

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global API Contract Manufacturing Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Reports
  • Dec 2020
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global API Contract Manufacturing Market, By Type (Organic, Inorganic, Others), Volume (Low, Large, Medium, Others), Form (Solid, Liquid, Semi-Solids, Others) End-Users (Pharmaceutical Industries, Research Organization, Others), Distribution Channel (Direct Tender, Retailers, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

API Contract Manufacturing Market Market Analysis and Insights: Global API Contract Manufacturing Market

Global API contract manufacturing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 9.90% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.

Technological advancement in production of API which is proven to be highly effective in meeting regulatory requirements and high demand for novel bio-generic drugs also boost up the market growth. Moreover, increasing demand for cost-efficient therapeutics in developing regions and increase in approval of new drugs for treatment of chronic diseases act as an opportunity for the market growth. However, long process for manufacturing and stringent rules & regulations in relation to facilities and equipment required for sterile small-molecule drugs, may hamper the global API contract manufacturing market.

For 2017, the API contract manufacturing market alone is estimated at about $70-75 billion including clinical supplies, active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

This API contract manufacturing market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global API Contract Manufacturing Market Scope and Market Size

The API contract manufacturing market is segmented on the basis of type, volume, form end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the API contract manufacturing market is segmented into organic, inorganic, and others.
  • On the basis of volume, the API contract manufacturing market is segmented into low, large, medium and others.
  • On the basis of form, the API contract manufacturing market is segmented into solid, liquid, semi solids and others.
  • On the basis of end-users, the API contract manufacturing market is segmented into pharmaceutical industries, research organization and others.
  • On the basis of distribution channel, the API contract manufacturing market has also been segmented into direct tender, retailers and others.

API Contract Manufacturing Market Country Level Analysis

API contract manufacturing market is analysed and market size information is provided by country, type, volume, form, end-users and distribution channel as referenced above.

The countries covered in the API contract manufacturing market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share in API contract manufacturing market due to the presence of high healthcare expenditure and rising requirement for new bio-generic drugs. Asia-Pacific is expected to account for the largest market share over coming years for the API contract manufacturing market due to reduced cost of production of APIs, availability of required skilled labour at an effective cost, favorable government policies, tax benefits and better trade relationships.

The country section of the API contract manufacturing market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and API Contract Manufacturing Market Share Analysis

API contract manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to API contract manufacturing market.

The major players covered in the API contract manufacturing market are Teva Pharmaceuticals Industries Ltd, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Piramal Pharma Solutions, Sandoz AG, GlaxoSmithKline Plc., Lupin, and Juniper Pharmaceutical among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

North America dominates the API contract manufacturing market due to the presence of high healthcare expenditure and rising requirement for new bio-generic drugs.
The growth rate of the API contract manufacturing market is 9.90%.
Technological advancement in production of API & high demand for novel bio-generic drugs are the growth drivers of the API contract manufacturing market.
Type, volume, form end-users and distribution channel are the factors on which the API contract manufacturing market research is based.
Major companies in the API contract manufacturing market are Teva Pharmaceuticals Industries Ltd, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Piramal Pharma Solutions, Sandoz AG, GlaxoSmithKline Plc., Lupin, and Juniper Pharmaceutical among other domestic and global players
a